Clinical trials: Angiofibromas, active
Juvenile Nasopharyngeal Angiofibroma
Efficacy and Safety of Sirolimus in Children and Adolescents With Juvenile Nasopharyngeal Angiofibroma (JNA)
Juvenile nasopharyngeal angiofibroma (JNA) is a pathologically benign yet locally aggressive and destructive tumor that develops in the choana and nasopharynx.
- Trial name
- NCT05549167
- Testing
- Sirolimus
- Where
- Russia
- Volunteers
- 117 people
- Sponsor
- Federal Research Institute of Pediatric Hematology, Oncology and Immunology